Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in Urol Int

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    December 2021
  1. CROCEROSSA F, Carbonara U, Parekh J, Urdaneta A, et al
    PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer.
    Urol Int. 2021 Dec 21:1-8. doi: 10.1159/000520684.
    PubMed     Abstract available


  2. BERG S, Tully KH, von Landenberg N, Bahlburg H, et al
    How Many Cores Should Be Sampled during Systematic Prostate Biopsy in Case of Negative Multiparametric Magnetic Resonance Imaging? Analysis of 274 Men with Clinical Suspicion of Prostate Cancer.
    Urol Int. 2021 Dec 20:1-6. doi: 10.1159/000520598.
    PubMed     Abstract available


    November 2021
  3. FLEGAR L, Baunacke M, Buerk BT, Proschmann R, et al
    Decision Regret and Quality of Life after Focal Therapy with Vascular-Targeted Photodynamic Therapy (TOOKAD(R)) for Localized Prostate Cancer.
    Urol Int. 2021 Nov 23:1-6. doi: 10.1159/000520084.
    PubMed     Abstract available


  4. VESTRIS PG, Giwerc A, Hennequin C, Goujon A, et al
    Operative and Midterm Oncological Outcome of Focal Salvage Cryotherapy for Localized Prostate Cancer.
    Urol Int. 2021 Nov 15:1-6. doi: 10.1159/000518980.
    PubMed     Abstract available


    October 2021
  5. CETIN B, Wabl CA, Gumusay O
    Optimal Treatment for Patients with Oligometastatic Prostate Cancer.
    Urol Int. 2021 Oct 26:1-10. doi: 10.1159/000519386.
    PubMed     Abstract available


  6. GUO Y, Tian Y, Deng Y, Lu C, et al
    Diagnostic Performance of [18F]-Labeled PET/CT Tracers for Lymph Node/Bone Metastasis and Biochemical Recurrence Detection in Advanced Prostate Cancer: A Meta-Analysis.
    Urol Int. 2021 Oct 13:1-19. doi: 10.1159/000518478.
    PubMed     Abstract available


    September 2021
  7. LI Y, Cheng X, Zhu JL, Luo WW, et al
    Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis.
    Urol Int. 2021 Sep 8:1-9. doi: 10.1159/000518164.
    PubMed     Abstract available


    August 2021
  8. SONG P, Shu M, Yang L, Di X, et al
    The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
    Urol Int. 2021 Aug 26:1-9. doi: 10.1159/000518113.
    PubMed     Abstract available


  9. PETERS R, Stephan C, Jung K, Lein M, et al
    Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.
    Urol Int. 2021 Aug 25:1-6. doi: 10.1159/000517891.
    PubMed     Abstract available


    July 2021
  10. TIAN B, Chunxiang E, Xiang Y, Teng P, et al
    Long Noncoding RNA LIPE-AS1 Drives Prostate Cancer Progression by Functioning as a Competing Endogenous RNA for microRNA-654-3p and Thereby Upregulating Hepatoma-Derived Growth Factor.
    Urol Int. 2021 Jul 7:1-16. doi: 10.1159/000516676.
    PubMed     Abstract available


    June 2021
  11. FERRO M, Terracciano D, Musi G, de Cobelli O, et al
    Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
    Urol Int. 2021 Jun 24:1-8. doi: 10.1159/000516680.
    PubMed     Abstract available


    May 2021
  12. KOPP D, Kopp J, Bernhardt E, Manka L, et al
    68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate Cancer.
    Urol Int. 2021 May 7:1-7. doi: 10.1159/000515651.
    PubMed     Abstract available


  13. PORCARO AB, Siracusano S, Amigoni N, Tafuri A, et al
    The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.
    Urol Int. 2021 May 7:1-9. doi: 10.1159/000514391.
    PubMed     Abstract available


  14. CELIK S, Kizilay F, Yorukoglu K, Aslan G, et al
    Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey.
    Urol Int. 2021 May 5:1-9. doi: 10.1159/000513658.
    PubMed     Abstract available


    March 2021
  15. ZHANG Q, Huang J, Xie C, Wu T, et al
    Adjuvant Chemotherapy in High-Risk Prostate Cancer Patients after Primary Local Therapy: Recurrence, Metastasis, and Survival - A Meta-Analysis.
    Urol Int. 2021 Mar 30:1-8. doi: 10.1159/000513941.
    PubMed     Abstract available


    January 2021
  16. HERDEN J, Schwarte A, Boedefeld EA, Weissbach L, et al
    Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.
    Urol Int. 2021 Jan 29:1-8. doi: 10.1159/000512893.
    PubMed     Abstract available


  17. VON LANDENBERG N, Hanske J, Noldus J, Roghmann F, et al
    Probability of Prostate Cancer Diagnosis following Negative Systematic and Targeted MRI: Transrectal Ultrasound Fusion Biopsy: A Real-Life Observational Study.
    Urol Int. 2021 Jan 26:1-7. doi: 10.1159/000513075.
    PubMed     Abstract available


  18. MAURER V, Stahlberg J, Schiffmann I, Marks P, et al
    Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database.
    Urol Int. 2021;105.
    PubMed     Abstract available


  19. SHEN Q, Zhou Z, Liu Z, Hu S, et al
    Clinical and Pathological Features of Prostatic Stromal Tumor of Uncertain Malignant Potential: A Retrospective Study of 23 Chinese Cases.
    Urol Int. 2021;105.
    PubMed     Abstract available


  20. GOSSLER C, May M, Breyer J, Stojanoski G, et al
    High BMI, Aggressive Tumours and Long Console Time Are Independent Predictive Factors for Symptomatic Lymphocele Formation after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection.
    Urol Int. 2021;105.
    PubMed     Abstract available


  21. XU B, Ma BL, Peng YJ, Zhang Q, et al
    Learning Curve of an Innovative "3-Port" Laparoscopic Radical Prostatectomy: A Single-Center Analysis from 2016 to 2019.
    Urol Int. 2021;105.
    PubMed     Abstract available


  22. SCHMITZ-DRAGER BJ, Muhlich S, Lange C, Benderska-Soder N, et al
    Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study.
    Urol Int. 2021;105.
    PubMed     Abstract available


  23. APFELBECK M, Schlenker B, Chaloupka M, Stief CG, et al
    Multiparametric MRI Lesion Classified as Prostate Imaging-Reporting and Data System 5 but Histopathologically Described as Benign: A Case Report and Review of Literature.
    Urol Int. 2021;105.
    PubMed     Abstract available


  24. NAKANISHI Y, Ito M, Kataoka M, Ikuta S, et al
    Who Can Avoid Biopsy of Magnetic Resonance Imaging-Negative Lobes without Compromising Significant Cancer Detection among Men with Unilateral Magnetic Resonance Imaging-Positive Lobes?
    Urol Int. 2021;105.
    PubMed     Abstract available


  25. PRATSINIS M, Babst C, Langenauer J, Schmid HP, et al
    Qualitative Assessment of Medical Information on YouTube: A Multilingual Comparison of Common Urological Conditions.
    Urol Int. 2021;105.
    PubMed     Abstract available


  26. MASSANOVA M, Robertson S, Barone B, Dutto L, et al
    The Comparison of Imaging and Clinical Methods to Estimate Prostate Volume: A Single-Centre Retrospective Study.
    Urol Int. 2021;105.
    PubMed     Abstract available


    December 2020
  27. LIU S, Wang XY, Huang TB, Ma XX, et al
    Impact of Radiotherapy on Prognosis in Patients Diagnosed with Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Dec 10:1-10. doi: 10.1159/000508415.
    PubMed     Abstract available


    October 2020
  28. TAFURI A, Rizzetto R, Amigoni N, Sebben M, et al
    Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
    Urol Int. 2020 Oct 15:1-8. doi: 10.1159/000510008.
    PubMed     Abstract available


    September 2020
  29. CHEN Y, Lan T
    Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer.
    Urol Int. 2020 Sep 21:1-17. doi: 10.1159/000510124.
    PubMed     Abstract available


  30. BERGIUS S, Roine RP, Taari K, Sintonen H, et al
    Health-Related Quality of Life and Survival in Prostate Cancer Patients in a Real-World Setting.
    Urol Int. 2020 Sep 21:1-9. doi: 10.1159/000510319.
    PubMed     Abstract available


    August 2020
  31. FANG WY, Wang PF, Fan YC, Shih HJ, et al
    Clinical Experience of Steroid Switch from Prednisone to Dexamethasone in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate.
    Urol Int. 2020 Aug 13:1-6. doi: 10.1159/000509882.
    PubMed     Abstract available


  32. NESTLER T, Wittersheim M, Schaefer S, Hellmich M, et al
    Prediction of Radioresistant Prostate Cancer Based on Differentially Expressed Proteins.
    Urol Int. 2020 Aug 13:1-12. doi: 10.1159/000509447.
    PubMed     Abstract available


  33. CLEMENTS MB, Abdalla B, Culp SH, Costabile RA, et al
    Prostate Cancer Characteristics in the US Preventive Services Task Force Grade D Era: A Single-Center Study and Meta-Analysis.
    Urol Int. 2020 Aug 6:1-7. doi: 10.1159/000507656.
    PubMed     Abstract available


  34. CELEN S, Gultekin A, Ozlulerden Y, Mete A, et al
    Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study.
    Urol Int. 2020 Aug 4:1-8. doi: 10.1159/000509974.
    PubMed     Abstract available


    July 2020
  35. SAAR M, Linxweiler J, Borkowetz A, Fussek S, et al
    Current Role of Multiparametric MRI and MRI Targeted Biopsies for Prostate Cancer Diagnosis in Germany: A Nationwide Survey.
    Urol Int. 2020 Jul 8:1-10. doi: 10.1159/000508755.
    PubMed     Abstract available


    May 2020
  36. TAFURI A, Sebben M, Pirozzi M, Processali T, et al
    Association between Basal Total Testosterone Levels and Prostate Cancer D'Amico Risk Classes.
    Urol Int. 2020 May 27:1-8. doi: 10.1159/000506525.
    PubMed     Abstract available


  37. SAWAZAKI H, Kitamura Y, Yagi K, Arai Y, et al
    Impact of Androgen Deprivation Therapy on Non-Alcoholic Fatty Liver Disease in Patients with Prostate Cancer: A CT Evaluation.
    Urol Int. 2020 May 12:1-6. doi: 10.1159/000507351.
    PubMed     Abstract available


  38. WESTHOFF N, Ritter M, Maros M, Rassweiler-Seyfried MC, et al
    Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer.
    Urol Int. 2020 May 12:1-8. doi: 10.1159/000507123.
    PubMed     Abstract available


  39. HENNENLOTTER J, Neumann T, Perner S, Wagner V, et al
    Impact of Histopathological Prostate Inflammation on Urine-Based Prostate Cancer Prediction Using the Prostate Cancer Gene 3 Score.
    Urol Int. 2020 May 8:1-6. doi: 10.1159/000506885.
    PubMed     Abstract available


    April 2020
  40. KAMEL MG, Istanbuly S, Abd-Elhay FA, Mohamed MYF, et al
    Examined and Positive Lymph Node Counts Are Associated with Mortality in Prostate Cancer: A Population-Based Analysis.
    Urol Int. 2020 Apr 8:1-11. doi: 10.1159/000505410.
    PubMed     Abstract available


    January 2020
  41. SCHULZE A, Christoph F, Sachs M, Schroeder J, et al
    Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies.
    Urol Int. 2020;104.
    PubMed     Abstract available


  42. YANG B, Zhang F, Xiao C, Lu J, et al
    Impact of Preoperative Magnetic Resonance Imaging Anatomic Features on Urinary Continence Recovery after Laparoscopic Radical Prostatectomy.
    Urol Int. 2020;104.
    PubMed     Abstract available


  43. ERB HHH, Sparwasser P, Diehl T, Hemmerlein-Thomas M, et al
    AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC.
    Urol Int. 2020;104.
    PubMed     Abstract available


  44. MAXEINER A, Nest AM, Stephan C, Cash H, et al
    Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
    Urol Int. 2020;104.
    PubMed     Abstract available


  45. LIU Y, Xiao G, Zhou JW, Yang JK, et al
    Optimal Starting Age and Baseline Level for Repeat Tests: Economic Concerns of PSA Screening for Chinese Men - 10-Year Experience of a Single Center.
    Urol Int. 2020;104.
    PubMed     Abstract available


  46. PARK J, Yoo S, Cho MC, Jeong CW, et al
    Patients with Biopsy Gleason Score 3 + 4 Are Not Appropriate Candidates for Active Surveillance.
    Urol Int. 2020;104.
    PubMed     Abstract available


  47. BERG S, Hanske J, von Landenberg N, Noldus J, et al
    Institutional Adoption and Apprenticeship of Fusion Targeted Prostate Biopsy: Does Experience Affect the Cancer Detection Rate?
    Urol Int. 2020;104.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: